GSK_ Annual_Report_2021-22

57 D r. (Ms.) Sunita Maheshwari – Independent Director (DIN: 01641411) Dr. Sunita Maheshwari, Outlook Business WOW 2019 (Woman of Worth) and 2014’s ‘Amazing Indian’ award by Times Now, is a US Board certified Pediatric Cardiologist who did her MBBS at Osmania Medical College, followed by her postgraduation at AIIMS, Delhi and Yale University in the US. She is the winner of the ‘Young Clinician Award’ from the American Heart Association and the ‘Best Teacher Award’ at Yale University. She was nominated as one of the Top 20 women achievers in medicine in India. Apart from her medical clinical work, she is a medical entrepreneur and cofounded and is the Chief Dreamer at Teleradiology Solutions (India’s first and largest teleradiology Company that has provided over 6 million diagnostic reports to patients and hospitals globally), Telrad tech which builds AI enabled tele health software, RXDX multi-specialty phygital clinics in Bangalore, and has incubated other start-up companies in the tele-health space such as Healtheminds, a tele-counselling platform. She is active in the social arena in India where she runs 2 trust funds. People4people has put up over 500 playgrounds in government schools and Telrad Foundation provides teleradiology and telemedicine services to poor areas in Asia that do not have access to high quality medical care. Her expertise is in the field of Medical Science. She is a member of the Corporate Social Responsibility Committee. She is also on the Board of HDFC Bank. M r. Mark Dawson – Non-Executive Director (DIN: 09032378) Mark Dawson is Vice President of Primary and Small Molecules Manufacturing (PSM) within GSK’s Pharmaceutical Business. Mr. Dawson is responsible for the supply chain that manufactures all GSK Primary (API) products, Antibiotics supply chain and Regional Rx manufacturing with 18 facilities located across Europe, MEA, India, China, Singapore, Japan, and Australia. He is also responsible for all supply chain planning, logistics and warehousing operations into 105 global markets from Latam, Middle East, Africa, Russia/CIS, India, Pakistan, China and South Asia. He is a member of the Global Supply Chain Executive Team and the Emerging Markets Leadership Team. He also sits as a member of GSK’s Global Gender Diversity Council. He joined GSK in 2005 working in various roles of increasing seniority within Global Manufacturing and Supply as Engineering Director, Site Director for the Irvine manufacturing site, VP and Head of Global Supply Chain within ViiV Healthcare (GSK’s HIV business), VP and Head of Supply Chain for Emerging Markets and latterly as VP and Head of Manufacturing and Supply Chain for Primary and Established Products. Prior to GSK, he has worked for several multinational companies including Eli Lilly & Company, Kvaerner and Schneider Electric. He is a graduate of the University of Sheffield in the UK and a Chartered Engineer. He has expertise in the field of Supply Chain. M r. Juby Chandy – Whole-time Director & Chief Financial Officer (DIN: 09530618) Mr. Juby Chandy, a Chartered Accountant, is an experienced finance Leader who has led GSK’s finance teams in various regions. Mr. Chandy joined GSK in 2007 and has held a number of leadership positions with increasing responsibilities across various geographies, including Finance Director for GSK’s Middle East business based in Turkey, Finance Director for GSK Vietnam, Finance Planning Director for Emerging Markets, Area Finance Director for Emerging Market East (South East Asia) and, most recently, Head of Finance for Global General Medicines portfolio, partnering with the leadership team on strategy, profit maximisation, and helping to drive performance for General Medicines. He is also a Director in Biddle Sawyer Limited. M r. Manu Anand – Independent Director (DIN: 00396716) Mr. Manu Anand, 63, is a Chartered Accountant and has completed Advance Management Program from the Wharton School of the University of Pennsylvania, USA. Mr. Manu brings the experience of over three decades, out of which he has been in the General Manager roles for the last 20 years with a track record of building diverse teams, driving growth, managing multi-billion-dollar P&Ls, and leading change and transformation. In his role with Mondelez International before his retirement, he managed the Chocolate business (approx $2 billion) operations across the Asia Pacific, Middle East, and Africa, covering a range of developed and developing markets. The role required managing the levers of P&L, driving top and bottom line and market share growth through a combination of region-wide and market-specific initiatives on the brands and innovation. In addition, he ran a consolidated supply chain with a complex manufacturing site network and worked closely with sales teams in markets to deliver sustained business performance. Mr. Manu was earlier leading the India business for Mondelez International and as Managing Director for Cadbury India Limited was responsible for all business functions; the role required a high degree of general management skills to steer the categories and functions appropriately to drive continued growth